فرشاة غسيل سيارات أوتوماتيكية دوارة بزاوية 360 درجة
وفر 9%! اشترِ فرشاة غسيل سيارات أوتوماتيكية دوارة بزاوية 360 درجة بسعر 274.95 د.
🛒 تسوق الآنAfrican Voices Call for Acceleration of Pharmaceutical System Transformation
Over 200 health leaders at International Pharmaceutical Forum demand urgent continental drug manufacturing reform
More than 200 decision-makers, academics, regulators, and health industry leaders gathered at the 25th edition of the International Pharmaceutical Forum (FPI) have issued a unified call to accelerate the transformation of Africa's pharmaceutical systems. The landmark gathering brought together voices from across the continent to address critical gaps in drug manufacturing, regulation, and access to essential medicines.
Continental Push for Pharmaceutical Sovereignty Gains Momentum
The forum's central declaration emphasized that Africa's dependence on imported pharmaceuticals poses a fundamental threat to public health security across the continent. Participants stressed that accelerating transformation of pharmaceutical manufacturing capabilities is no longer optional but an urgent necessity. The call to action came from a diverse coalition including government ministers, university researchers, regulatory officials, and private-sector health partners who agreed that the continent must chart a new course toward self-reliance in drug production.
According to the African Development Bank Group, which participated actively in the proceedings, Africa imports approximately 99% of its vaccines and over 70% of its essential medicines. This staggering dependency was described by forum participants as a systemic vulnerability that demands immediate and coordinated continental response. The Bank urged development partners to strengthen their engagement to consolidate institutional capacities and support sustainable pharmaceutical development across African nations.
Key Demands From the Forum
- Accelerate local pharmaceutical manufacturing to reduce import dependency from current levels above 70%
- Harmonize drug regulatory frameworks across African Union member states by 2025
- Establish continental pharmaceutical research and development hubs in at least 10 countries
- Increase health sector funding allocation to a minimum of 15% of national budgets per the Abuja Declaration
- Create a unified African medicines procurement mechanism to leverage continental market size
- Invest in training programs to produce 50,000 pharmaceutical scientists and technicians within the decade
Development Partners Urged to Scale Up Engagement
The African Development Bank Group issued a direct appeal to international development partners, calling for reinforced commitment to building robust pharmaceutical institutions across the continent. The Bank highlighted that consolidating institutional capacities requires sustained investment in regulatory infrastructure, quality control laboratories, and supply chain management systems. This aligns with broader calls from global financial institutions, including the IMF and World Bank, for African nations to accelerate structural reforms in key sectors.
During parallel discussions at recent international summits, including gatherings in Marrakech, African leaders and international financial institutions have repeatedly emphasized that the continent stands at a critical juncture. The concept of a "New South" has emerged as a framework for reimagining Africa's role in global pharmaceutical supply chains, with the transformation of health systems positioned as a cornerstone of this vision.
Why This Matters for Libya
For Libya, the continental push toward pharmaceutical transformation carries direct and significant implications. The country has faced persistent challenges in ensuring stable access to essential medicines, with supply chain disruptions exacerbated by years of political instability and conflict. Libya's pharmaceutical sector remains heavily dependent on imports, making it vulnerable to global supply disruptions and price volatility.
As the African Union advances its continental pharmaceutical strategy, Libya stands to benefit from harmonized regulatory standards, shared procurement mechanisms, and technology transfer partnerships. Libyan health authorities have previously signaled interest in developing local manufacturing capacity for essential generic medicines, and the forum's outcomes could provide the framework and international support needed to realize these ambitions. The acceleration of Africa's pharmaceutical transformation could ultimately reduce Libya's import dependency and strengthen its health security.
A Continental Vision for Health Security
The forum concluded with a shared commitment to establishing a follow-up mechanism that will track progress on pharmaceutical transformation goals across member states. Participants agreed to reconvene within six months to assess implementation milestones and address emerging challenges. The African Development Bank pledged to integrate pharmaceutical development financing into its broader health sector investment strategy, signaling that this agenda will remain a continental priority.
The voices rising from this forum represent more than a call for policy change — they signal a fundamental shift in how Africa approaches its own health sovereignty. For millions of Africans, including Libyans, the transformation of pharmaceutical systems means the difference between dependence and self-reliance, between vulnerability and resilience. The continent's leaders have made their position clear: the time for acceleration is now.
— LibyaPress / Libya Desk
===END_ENGLISH===